C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 95, Issue 5, 2003, Pages 586-593

  Edwards, Paul C ^a   Bhuiya, Tawfigul ^a   Kelsch, Robert D ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; POLYCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR; ANTIBODY; COLORING AGENT; DIAGNOSTIC AGENT; TUMOR MARKER;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MYELOID LEUKEMIA; PATHOLOGY; PROTEIN EXPRESSION; SALIVARY GLAND BIOPSY; SALIVARY GLAND TUMOR; SEMINOMA; TUMOR CELL; BIOPSY; COMPARATIVE STUDY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BIOPSY; CARCINOMA, ADENOID CYSTIC; COLORING AGENTS; CYTOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038500901     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2003.31     Document Type: Article

References (28)

1. Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 2000;154:107-11.
2. Arber DA, Tamayo R, Weiss LM.. Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders. Hum Pathol 1998;28:498-504.
3. Andersson J, Sjogren H, Meis-Kindblom JM, Stenman G, Aman P, Kindblom LG. The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker) tumors. Am J Pathol 2002;160:15-22.
4. Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumors. J Clin Pathol 2001;54:96-102.
5. Leroy X, Augusto D, Leteurtre E, Gosselin B. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem 2002;50:283-5.
6. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol 2002;26:493-7.
7. Smithey BE, Pappo AS, Hill DA. C-kit expression in pediatric solid tumors: a comparative immunohistochemical study. Am J Surg Pathol 2002;26:486-92.
8. Penner CR, Cox DP, Folpe AL, Budnick S. C-kit expression distinguishes adenoid cystic carcinoma (ACC) from polymorphous low-grade adenocarcinoma (PLGA). Abstract #892. 2001 United States and Canadian Academy of Pathology Annual Meeting; 2001 Mar 3-9; New Orleans, La.
9. Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 2002;15:687-91.
10. Ellis GL, Auclair PL. Tumors of the salivary gland. Atlas of tumor pathology. Third series. Fascicle 17. Washington: Armed Forces Institute of Pathology;1995.
11. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993;142:339-46.
12. Mino M, Pilch BZ, Faquin WC. Expression of c-kit in adenoid cystic carcinomas, salivary gland tumors and basaloid neoplasms of the head and neck. Abstract #930. 2002 United States and Canadian Academy of Pathology Annual Meeting; 2002 Feb 23-Mar 2; Chicago, Ill.
13. Liu CZ, Keelawat S, Barnes EL. Differential expression of c-kit distinguishes salivary gland adenoid cystic carcinoma (ACC) from basal cell adenocarcinoma (BCAC). Abstract #929. 2002 United States and Canadian Academy of Pathology Annual Meeting; 2002 Feb 23-Mar 2; Chicago, Ill.
14. Oprea GM, Khalil Z, Mesa H, Manivel JC, Setty S, Pambuccian SE. Value of c-kit (CD117) staining in the differential diagnosis of basaloid tumors of the head and neck. Abstract #934. 2002 United States and Canadian Academy of Pathology Annual Meeting; 2002 Feb 23-Mar 2; Chicago, Ill.
15. Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr. KIT expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999;12:956-60.
16. Oprea GM, Bachowski G, Lundeen SJ, Gulbahce HE, Coad JE, Pambuccian SE. C-kit (CD117) expression is higher in adenoid cystic carcinoma (ACC) arising in major salivary glands than in ACC arising in other locations. Abstract #93. 2002 United States and Canadian Academy of Pathology Annual Meeting; Chicago, Ill.
17. Cohn ML, Said-Al-Naif N, Bell WC. Immunoreactivity of salivary gland tumors for CK-7, CK-20 and C-kit. Abstract #910. 2002 United States and Canadian Academy of Pathology Annual Meeting; Chicago, Ill.
18. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcoma is very limited in distribution. Am J Clin Pathol 2002;117:188-93.
19. Simpson RH, Clarke TJ, Sarsfield PT, Gluckman PG, Babajews AV. Polymorphous low-grade adenocarcinoma of the salivary glands: a clinicopathological comparison with adenoid cystic carcinoma. Histopathology 1991;19:121-9.
20. Araujo VC, Loducca SV, Sousa SO, Williams DM, Araujo NS. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression. Ann Diagn Pathol 2001;5:330-4.
21. Skalova A, Simpson RH, Lehtonen H, Leivo I. Assessment of proliferative activity using the MIB1 antibody to help distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract 1997;193:695-703.
22. Prasad AR, Savera AT, Gown AM, Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med 1999;123:801-6.
23. Araujo VC, Carvalho YR, Araujo NS. Actin versus vimentin in myoepithelial cells of salivary gland tumors: A comparative study. Oral Surg Oral Med Oral Pathol 1994;77:387-91.
24. Curran A, Allen C, Beck F, Murrah V. Glial fibrillary acidic protein (GFAP) expression in basal cell and canalicular adenomas (BCA/CAN) vs. polymorphous low grade adenocarcinomas as an adjunct in diagnosis of morphologically similar cases. Abstract #11. 2002 American Association of Oral and Maxillofacial Pathology Annual Meeting; 2002 Apr 20-24; New Orleans, La.
25. Regezi JA, Zarbo RJ, Stewart JC, Courtney RM. Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol 1991;71:469-75.
26. Curran AE, White DK, Damm DD, Murrah VA. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:194-9.
27. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-6.
28. Demetri GD. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol 2001;28:19-26.